Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Co-Diagnostics to Participate in Global Health Roundtable on Ebola and Outbreak Innovation

21 September 2026 · By · Wire by Fusion42

Published

21 September 2026

Topic

opportunities

◆ Sectors

Diagnostics

◆ Geography

Africa

◆ Source

Read at biospace.com →

◆ Verified

Fusion42 · 21 September 2026 · Fusion42 review

Co-Diagnostics is participating in a global health roundtable on Ebola to discuss technologies and partnerships for outbreak response. The company is advancing diagnostic solutions for the ongoing Bundibugyo Ebola outbreak and collaborating on blood-based molecular testing at point of need.

This Wire brief sits within Fusion42's coverage of Diagnostics.

◆ ◆ The Wire takeaway

You can now target Ebola outbreak response with new blood-based molecular testing workflows that cut time to diagnosis. Co-Diagnostics' collaboration opens doors to rapid test deployment in Africa and beyond.

◆ Coverage

1 source · 21 Sep 2026

◆ Related on Wire

◆ Topics

Diagnosticseboladiagnosticsoutbreak-responsemolecular-testinghealthtech